Gavi an­nounces $1.8B for vac­cine ac­cess, pan­dem­ic pre­pared­ness ef­forts in Africa

The glob­al health part­ner­ship Gavi is look­ing to ramp up vac­cine ac­cess in Africa through a slate of pro­grams that puts up $1.8 bil­lion to bol­ster vac­cine man­u­fac­tur­ing, strength­en pan­dem­ic pre­pared­ness and pro­vide rou­tine vac­ci­na­tions to chil­dren.

Dur­ing a two-day meet­ing host­ed by the Ghana­ian gov­ern­ment, Gavi’s board ap­proved the es­tab­lish­ment of a fi­nance mech­a­nism — dubbed the African Vac­cine Man­u­fac­tur­ing Ac­cel­er­a­tor — which will make a to­tal of up to $1 bil­lion avail­able to sup­port vac­cine man­u­fac­tur­ing ef­forts. The or­ga­ni­za­tion said the de­ci­sion fol­lows 18 months of “close col­lab­o­ra­tion” with the African Union and Africa CDC.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER